QQQ $ 494.79 $ 2.89 (0.59 %)
DIA $ 400.37 $ 2.69 (0.68 %)
SPY $ 559.91 $ 3.51 (0.63 %)
TLT $ 93.88 $ 0.40 (0.43 %)
GLD $ 223.10 $ -0.14 (-0.06 %)
$ 0.478
-- x --
-- x --
-- - --
$ 0.25 - $ 0.50
40,403
na
35.36M
$ -0.02
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-14-2023 12-31-2022 10-Q
2 11-10-2022 09-30-2022 10-Q
3 08-11-2022 06-30-2022 10-Q
4 06-14-2022 03-31-2022 10-K
5 02-11-2022 12-31-2021 10-Q
6 11-12-2021 09-30-2021 10-Q
7 08-12-2021 06-30-2021 10-Q
8 06-09-2021 03-31-2021 10-K
9 02-09-2021 12-31-2020 10-Q
10 11-13-2020 09-30-2020 10-Q
11 08-11-2020 06-30-2020 10-Q
12 06-10-2020 03-31-2020 10-K
13 02-10-2020 12-31-2019 10-Q
14 11-08-2019 09-30-2019 10-Q
15 08-09-2019 06-30-2019 10-Q
16 06-11-2019 03-31-2019 10-K
17 02-07-2019 12-31-2018 10-Q
18 11-07-2018 09-30-2018 10-Q
19 08-07-2018 06-30-2018 10-Q
20 06-11-2018 03-31-2018 10-K
21 02-09-2018 12-31-2017 10-Q
22 11-02-2017 09-30-2017 10-Q
23 08-07-2017 06-30-2017 10-Q
24 06-13-2017 03-31-2017 10-K
25 02-14-2017 12-31-2016 10-Q
26 11-07-2016 09-30-2016 10-Q
27 08-15-2016 06-30-2016 10-Q
28 06-06-2016 03-31-2016 10-K
29 02-09-2016 12-31-2015 10-Q
30 11-02-2015 09-30-2015 10-Q
31 08-11-2015 06-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 axovant-gene-therapies-announces-name-change-to-sio-gene-therapies

Rebranding to Sio Gene Therapies to reflect an independent company with a scientific strategy focused on disease-modifying an...

 axovant-gene-therapies-announces-fda-clearance-of-ind-for-axo-aav-gm2-gene-therapy-in-tay-sachs-and-sandhoff-diseases

AXO-AAV-GM2 is the first investigational gene therapy to receive IND clearance in Tay-Sachs and Sandhoff diseases Represen...

 68-biggest-movers-from-yesterday
68 Biggest Movers From Yesterday
11/09/2020 10:18:42

Gainers

 76-biggest-movers-from-friday
76 Biggest Movers From Friday
11/02/2020 09:20:11

Gainers Marine Petroleum Trust (NASDAQ: MARPS) shares climbed 35.4% to close at $3.33 on Friday.

Core News & Articles

Toward the end of trading Friday, the Dow traded down 1.45% to 26,272.64 while the NASDAQ fell 2.93% to 10,857.97. The S&P ...

Core News & Articles

Gainers Marine Petroleum Trust (NASDAQ: MARPS) shares jumped 121.5% to $5.45.

Core News & Articles

Midway through trading Friday, the Dow traded down 1.31% to 26,310.67 while the NASDAQ fell 2.78% to 10,874.14. The S&P als...

Core News & Articles

Following the market opening Friday, the Dow traded down 0.61% to 26,496.09 while the NASDAQ fell 1.92% to 10,970.56. The S&am...

 the-daily-biotech-pulse-novavax-vaccine-data-axovant-flags-delay-in-parkinsons-study-2-biotechs-make-wall-street-debuts

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitti...

 36-stocks-moving-in-fridays-pre-market-session

Gainers Air Industries Group (NASDAQ: AIRI) rose 53% to $1.58 in pre-market trading after the company Reported Thursday that...

Core News & Articles

Gainers Equillium (NASDAQ:EQ) shares increased by 16.5% to $6.99 during Thursday's after-market session. Equillium's t...

 axovant-gene-therapies-to-present-axo-lenti-pd-program-update-during-virtual-parkinsons-disease-rd-day-on-october-30-2020

Patient-level data in cohort 2 of SUNRISE-PD study demonstrates consistent, clinically meaningful outcomes and evidence of do...

 the-week-ahead-in-biotech-kala-fda-decision-merck--pfizer-earnings-vaccine-updates-and-ipos

Biotech stocks posted weekly declines in the week ended Oct. 23, pressured by the broader market decline amid mixed earnings re...

Core News & Articles

Today's 5 Stock Ideas:  Apple (AAPL) - Will host an event Tuesday to unveil the new iPhone. The event will begin at 1 p....

 the-daily-biotech-pulse-jj-pauses-coronavirus-vaccine-studies-voyagers-huntingtons-disease-study-placed-on-hold-altimmune-vaccine-data

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitti...

 axovant-gene-therapies-receives-rare-pediatric-disease-designation-for-axo-aav-gm2-for-tay-sachs-and-sandhoff-disease

Axovant Gene Therapies Ltd. (NASDAQ:AXGT), a clinical-stage company developing innovative gene therapies for neurological disea...

 the-daily-biotech-pulse-fda-panel-review-for-alkermes-axovant-gets-rare-pediatric-disease-designation-2-ipos

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitti...

 axovant-gene-therapies-receives-rare-pediatric-disease-designation-for-axo-aav-gm1-for-gm1-gangliosidosis

NEW YORK, Oct. 09, 2020 (GLOBE NEWSWIRE) -- Axovant Gene Therapies Ltd. (NASDAQ:AXGT), a clinical-stage company developing inno...